ScopusElsevier Scopus
Status
Active
Coverage
2005–present
Source type
Journal
Open access
No
CiteScore
0.9
SJR · SCImago
0.267
Q3 SJR quartile
H-index
31
Best quartile
Q4 · 24th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 67 / 88 | 24th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nephrologie et Therapeutique
Nephrologie et Therapeutique is Scopus-indexed (Q4, CiteScore 0.9), WoS SCIE. Published by John Libbey.
Checked against the index lists dated .
ISSN 1769-7255Verify ISSN ↗1872-9177Verify ISSN ↗
Publisher: John Libbey
Scopus · Q4WoS · SCIE
0.9
CiteScore 2025
Q4
Best quartile
2
Indexed in
Cost to publish: About US$1,780 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Nephrologie et Therapeutique indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q4, CiteScore 0.9.
What quartile is Nephrologie et Therapeutique in Scopus?
Nephrologie et Therapeutique is Q4 in Nephrology (rank 67 of 88), by CiteScore 2025.
What is the impact factor of Nephrologie et Therapeutique?
Nephrologie et Therapeutique is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.9, which places it in quartile Q4 at the 24th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.267, quartile Q3, with an H-index of 31.
How much does it cost to publish in Nephrologie et Therapeutique?
The publisher lists an article processing charge of about US$1,780 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Nephrologie et Therapeutique and what is its ISSN?
Nephrologie et Therapeutique is published by John Libbey. Its print ISSN is 1769-7255 and its online ISSN is 1872-9177.
Is Nephrologie et Therapeutique in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Nephrologie et Therapeutique open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Nephrologie et Therapeutique? — open metrics via OpenAlex
Nephrologie et Therapeutique has an h-index of 34 and a 2-year mean of 0.35 citations per paper (OpenAlex). Its Scopus CiteScore is 0.9, quartile Q4. On 2-year citations it ranks #71 of 87 Scopus journals in Nephrology.
34
h-index
0.35
2-yr mean citations
232
i10-index
6,331
works indexed
8,964
total citations
Publication fee · open access list price, US$
US$1,780
2-yr mean citations, among Scopus journals in the same subject
#71 of 87 Bottom 19% Nephrology
Nephrologie et Therapeutique published 55 papers in 2025; its busiest recent year was 2022 with 499. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Nephrologie et Therapeutique? — latest 84 articles, 2024–2026
In its latest 84 research articles (2024–2026), authors are most often from France (70.5%), Belgium (6.7%) and Tunisia (3.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Nephrologie et Therapeutique? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 0.3 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration70.5% of recent authorship from France
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
OCL - Oleagineux Corps Gras Lipides DOAJ Phytotherapie Scopus Q4 Revue Francaise de Gestion Scopus Q4 Sang Thrombose Vaisseaux Scopus Q4 Sciences Sociales et Sante WoS SSCI Virologie Scopus Q4 WoS SCIE Annales de Biologie Clinique Scopus Q3 WoS SCIE Annales Francaises de Medecine d'Urgence Scopus Q4 WoS ESCI
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.